Physician profile
Tara Baxter
NPI 1679189112
$5,677.81
in general payments reported to CMS, 2019-2025
14 companies · $1,497 in 2025
The $1,497 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,573 · 2022: $159 · 2023: $73.76 · 2024: $375 · 2025: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429 · Travel and Lodging: $499 · Education: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.77 |
| Travel and Lodging | $498.50 |
| Education | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,572.77 | 2021 | |
| Stryker Corporation | $688.13 | 2022-2025 | Mako, Triathlon, Gamma |
| Zimmer Biomet Holdings, INC. | $568.54 | 2025 | Oxford |
| Vertex Pharmaceuticals Incorporated | $234.60 | 2024-2025 | |
| Smith+Nephew, INC. | $142.87 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $111.82 | 2025 | Xcell |
| Davol INC. | $98.26 | 2022 | |
| Convatec INC. | $63.99 | 2022-2025 | |
| Vericel Corporation | $54.84 | 2024-2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $45.94 | 2025 | Iovera |
| Access Pro Medical, LLC | $28.90 | 2025 | Matriderm |
| Ethicon US, LLC | $23.40 | 2025 | Stratafix |
| Solventum Corporation | $22.67 | 2025 | Prevena |
| Polynovo North America LLC | $21.08 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.